New Horizon Health finds formula for profits ahead of schedule
One of China’s leading makers of early cancer screening products recorded an adjusted profit in the first half of the year as its revenue more than tripled Key Takeaways: New…
6606.HK
Relieved of ‘high-risk’ marker, New Horizon Health aims to break even next year
Encouraged by its fast-growing revenue last year, the cancer screening device maker believes its losses may end in 2023 Key Takeaways: New Horizon Health is expected to attract more investors…
6606.HK
FAST NEWS: New Horizon Health Says Revenue Tripled in 2022
The latest: Cancer-screening device maker New Horizon Health Ltd. (6606.HK) said on Thursday it expects to report its revenue rose to between 750 million yuan ($110 million) to 783 million…
FAST NEWS: New Horizon Health’s Loss Narrows on Booming Sales
The latest: Cancer-screening device maker New Horizon Health Ltd. (6606.HK) announced Friday that it lost 65.28 million yuan ($9.7 million) in the first half of the year, down significantly from…
FAST NEWS: New Horizon Health Sees 2021 Revenue Tripling
The latest: New Horizon Health Ltd. (6606.HK) said it expects to post full-year 2021 revenue of 205 million ($32.3 million) to 217 million yuan, up 191% to 208% from the previous year,…
New Horizon Health Gets Booster with New Product Approval
Company says its UU Tube used to self-screen for stomach cancer has been approved by China’s health regulator Key takeaways: New Horizon Health says its first-of-its-kind UU Tube self-screening product…
